Cellebrite DI (CLBT) Beginning Cash Balance (2021 - 2025)

Cellebrite DI's Beginning Cash Balance history runs 5 years deep, the most recent figure standing at $281.4 million for Q4 2025.

• On a quarterly basis, Beginning Cash Balance rose 106.35% year-over-year to $281.4 million in Q4 2025; TTM through Dec 2025 was $652.2 million, a 50.7% increase from a year earlier, with the FY2025 full-year figure at $191.7 million, up 1.13% from the prior year.
• Beginning Cash Balance grew to $281.4 million in Q4 2025 per CLBT's latest filing, from $179.2 million in the prior quarter.
• Across five years, Beginning Cash Balance topped out at $281.4 million in Q4 2025 and bottomed at $84.6 million in Q4 2022.
• The 5-year median for Beginning Cash Balance is $135.1 million (2021), against an average of $140.1 million.
• Across the five-year window, Beginning Cash Balance tumbled 46.51% in 2022 and surged 116.23% in 2024, its largest moves.
• Year by year, Beginning Cash Balance stood at $109.9 million in 2021, then slipped by 23.04% to $84.6 million in 2022, then surged by 62.08% to $137.1 million in 2023, then slipped by 0.52% to $136.3 million in 2024, then surged by 106.35% to $281.4 million in 2025.
• Per Business Quant, the three latest CLBT Beginning Cash Balance figures stand at $281.4 million (Q4 2025), $179.2 million (Q3 2025), and $191.7 million (Q1 2025).